Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie
0718.953.013 · rovalta.com · 28/09/2026
ACTIVE
Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie
Financial year 2025 · Closed on 30/09/2025
Net result507,8 k €-1,2 %over 1 year
Gross margin839,1 k €+24,7 %over 1 year
Equity567,2 k €-2,4 %over 1 year
Overview
Identity
Source · BCE/KBODr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Wortegem-Petegem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0718.953.013
- Incorporation
- 21/01/2019
- Legal form
- Private limited company
- Registered office
- Peerdekouterstraat (W.) 10
9790 Wortegem-Petegem · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 839,1 k € | +24.7% | 673,2 k € | -4.8% | 707,5 k € | +50.4% | 470,5 k € | +86.5% | 252,2 k € |
| EBITDA | 837,9 k € | +24.9% | 670,9 k € | -4.8% | 704,7 k € | +50.5% | 468,1 k € | +86.3% | 251,3 k € |
| Operating result | 680,8 k € | +2.9% | 661,6 k € | -4.7% | 694,1 k € | +52.1% | 456,4 k € | +90.1% | 240,1 k € |
| Net result | 507,8 k € | -1.2% | 514,2 k € | -1.5% | 521,8 k € | +49.2% | 349,8 k € | +91.4% | 182,7 k € |
| Balance sheet | |||||||||
| Equity | 567,2 k € | -2.4% | 581,4 k € | +7.2% | 542,2 k € | +40.4% | 386,1 k € | +26.9% | 304,2 k € |
| Total assets | 1,7 M € | +182% | 593,7 k € | -2.4% | 608,3 k € | +47.6% | 412,1 k € | +22.9% | 335,2 k € |
| Cash | 182,8 k € | -16.5% | 218,9 k € | -29.7% | 311,5 k € | -5.2% | 328,5 k € | +19.3% | 275,5 k € |
| Debts | 1,1 M € | +11531% | 9,5 k € | -85.6% | 65,9 k € | +154% | 26 k € | -16.1% | 31 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/09/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Gertjan Vereecke | Director | ||
Laura Leysen | DirectorManagerended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Gert-Jan Vereecke | Manager |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/03/2026 | 28/04/2025 | 27/03/2024 | 20/04/2023 | 27/04/2022 | 29/04/2021 |
| General meeting | 02/03/2026 | 31/03/2025 | 04/03/2024 | 06/03/2023 | 07/03/2022 | 22/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 02/03/2026 | 30/03/2026 | Dutch | |
| Abridged model | 30/09/2024 | 31/03/2025 | 28/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 04/03/2024 | 27/03/2024 | Dutch | |
| Micro model | 30/09/2022 | 06/03/2023 | 20/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 07/03/2022 | 27/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 22/03/2021 | 29/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 02/03/2020 | 30/04/2020 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Gertjan Vereecke | Director | ||
Laura Leysen | DirectorManagerended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Gert-Jan Vereecke | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/11/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates05/08/2020ONTSLAGEN - BENOEMINGEN
- Registered office06/08/2019MAATSCHAPPELIJKE ZETEL
- Other23/01/2019RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
20192020202120222023202420252026
Dr. Leysen - Ophtalmologie & Dr. Vereecke - EndocrinologieDr. Leysen - Ophtalmologie & Dr. Vereecke - Endocr
Peerdekouterstraat (W.) 10, 9790 Wortegem-PetegemBerchemweg 337 bte 501, 9700 Oudenaarde
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Peerdekouterstraat (W.) 10, 9790 Wortegem-PetegemCurrent | accounts 2023 → 2025 | Accounts 2025 · 2026-00066491 |
| Berchemweg 337 bte 501, 9700 Oudenaarde | accounts 2021 → 2022 | Accounts 2022 · 2023-00063876 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Leysen - Ophtalmologie & Dr. Vereecke - EndocrinologieCurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00066491 |
| Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocr | accounts 2022 → 2023 | Accounts 2023 · 2024-00054697 |
| Veledok | accounts 2021 | Accounts 2021 · 2022-20018899 |
Events
- 2025Annual accounts 2025507,8 k €↓
- 2024Annual accounts 2024514,2 k €↓
- 2024Name changeDr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie
- 2023Annual accounts 2023521,8 k €↑
- 2022Annual accounts 2022349,8 k €↑
- 2022Name changeDr. Leysen - Ophtalmologie & Dr. Vereecke - Endocr
- 2021Annual accounts 2021182,7 k €↑
- 2020Annual accounts 202093,4 k €↑
- 2019Annual accounts 201915,7 k €
- 21/01/2019IncorporationPrivate limited company